Last updated: 28 September 2023 at 5:30pm EST

Nancy Stuart Net Worth




The estimated Net Worth of Nancy Stuart is at least $4.92 Миллион dollars as of 15 February 2023. Ms. Stuart owns over 6,048 units of Concert Pharmaceuticals Inc stock worth over $2,197,929 and over the last 10 years she sold CNCE stock worth over $815,155. In addition, she makes $1,908,030 as Chief Operating Officer at Concert Pharmaceuticals Inc.

Ms. Stuart CNCE stock SEC Form 4 insiders trading

Nancy has made over 20 trades of the Concert Pharmaceuticals Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently she sold 6,048 units of CNCE stock worth $50,380 on 15 February 2023.

The largest trade she's ever made was exercising 48,882 units of Concert Pharmaceuticals Inc stock on 25 January 2018 worth over $223,880. On average, Nancy trades about 8,152 units every 86 days since 2014. As of 15 February 2023 she still owns at least 262,596 units of Concert Pharmaceuticals Inc stock.

You can see the complete history of Ms. Stuart stock trades at the bottom of the page.





Nancy Stuart biography

Nancy Stuart serves as Chief Operating Officer of the Company. Ms. Stuart has served as our Chief Operating Officer since October 2007 and was our Senior Vice President, Corporate Strategy and Operations from July 2006 to October 2007. Prior to joining Concert, Ms. Stuart held various business operations and business development positions at Amgen Inc., a biopharmaceutical company, Kinetix Pharmaceuticals, Inc., a pharmaceutical company subsequently acquired by Amgen, Scion Pharmaceuticals, Inc., a pharmaceutical company, Vertex Pharmaceuticals Incorporated, a pharmaceutical company, and Genzyme Corporation, a biotechnology company. Ms. Stuart received a B.S. from the University of Michigan and an M.B.A. from the Simmons College Graduate School of Management.

What is the salary of Nancy Stuart?

As the Chief Operating Officer of Concert Pharmaceuticals Inc, the total compensation of Nancy Stuart at Concert Pharmaceuticals Inc is $1,908,030. There are 1 executives at Concert Pharmaceuticals Inc getting paid more, with Roger Tung having the highest compensation of $2,772,350.



How old is Nancy Stuart?

Nancy Stuart is 62, she's been the Chief Operating Officer of Concert Pharmaceuticals Inc since 2007. There are 7 older and 8 younger executives at Concert Pharmaceuticals Inc. The oldest executive at Concert Pharmaceuticals Inc is Peter Hutt, 85, who is the Independent Director.

What's Nancy Stuart's mailing address?

Nancy's mailing address filed with the SEC is C/O KALVISTA PHARMACEUTICALS, INC., 55 CAMBRIDGE PARKWAY, SUITE 901E, CAMBRIDGE, MA, 02142.

Insiders trading at Concert Pharmaceuticals Inc

Over the last 11 years, insiders at Concert Pharmaceuticals Inc have traded over $69,766,120 worth of Concert Pharmaceuticals Inc stock and bought 1,926,078 units worth $25,219,472 . The most active insiders traders include Plc Gsk, Associates Gp Llcqvt Fund V... и Partners L P/Ilbiotechnolog.... On average, Concert Pharmaceuticals Inc executives and independent directors trade stock every 28 days with the average trade being worth of $447,820. The most recent stock trade was executed by Nancy Stuart on 15 February 2023, trading 6,048 units of CNCE stock currently worth $50,380.



What does Concert Pharmaceuticals Inc do?

Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert's lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates.



What does Concert Pharmaceuticals Inc's logo look like?

Concert Pharmaceuticals Inc logo

Complete history of Ms. Stuart stock trades at Concert Pharmaceuticals Inc и KalVista Pharmaceuticals Inc

Дата
#
Компания
инсайдер
Транзакция
Транзакция
Акции Цена за акцию Общая стоимость Акции после Источник
15 Feb 2023 Nancy Stuart
Главный операционный директор
Продажа 6,048 $8.33 $50,380
15 Feb 2023
262,596
30 Jan 2023 Nancy Stuart
Главный операционный директор
Продажа 13,200 $8.35 $110,220
30 Jan 2023
268,644
6 Jan 2023 Nancy Stuart
Главный операционный директор
Продажа 2,893 $7.25 $20,974
6 Jan 2023
281,844
14 Feb 2022 Nancy Stuart
Главный операционный директор
Продажа 6,049 $3.08 $18,631
14 Feb 2022
284,737
5 Jan 2022 Nancy Stuart
Главный операционный директор
Продажа 2,894 $3.19 $9,232
5 Jan 2022
170,386
16 Feb 2021 Nancy Stuart
Главный операционный директор
Продажа 6,049 $7.32 $44,279
16 Feb 2021
173,280
22 Jun 2020 Nancy Stuart
Главный операционный директор
Реализация опциона 21,238 $3.79 $80,492
22 Jun 2020
167,924
4 Dec 2019 Nancy Stuart
Главный операционный директор
Реализация опциона 5,896 $4.41 $26,001
4 Dec 2019
104,739
6 Feb 2019 Nancy Stuart
Главный операционный директор
Реализация опциона 28,616 $4.41 $126,197
6 Feb 2019
116,724
9 Jul 2018 Nancy Stuart
Главный операционный директор
Продажа 31,418 $17.87 $561,440
9 Jul 2018
89,958
25 Jan 2018 Nancy Stuart
Главный операционный директор
Реализация опциона 48,882 $4.58 $223,880
25 Jan 2018
151,860
14 Nov 2017 Nancy Stuart
Главный операционный директор
Реализация опциона 4,215 $4.58 $19,305
14 Nov 2017
105,117
8 Mar 2017 Nancy Stuart
Главный операционный директор
Реализация опциона 2,098 $1.13 $2,371
8 Mar 2017
41,049
6 Dec 2016 Nancy Stuart
Главный операционный директор
Реализация опциона 7,100 $1.13 $8,023
6 Dec 2016
39,848
11 Nov 2015 Nancy Stuart
Главный операционный директор
Реализация опциона 9,200 $1.13 $10,396
11 Nov 2015
34,204
11 Nov 2015 Nancy Stuart
Главный операционный директор
Реализация опциона 9,200 $1.13 $10,396
11 Nov 2015
34,204
2 Nov 2015 Nancy Stuart
Главный операционный директор
Реализация опциона 23,216 $0.57 $13,233
2 Nov 2015
48,220
14 Sep 2015 Nancy Stuart
Главный операционный директор
Реализация опциона 17,000 $1.13 $19,210
14 Sep 2015
26,000
11 Mar 2015 Nancy Stuart
Главный операционный директор
Реализация опциона 46,430 $0.57 $26,465
11 Mar 2015
56,430
29 May 2014 Nancy Stuart
Главный операционный директор
Реализация опциона 10,000 $0.57 $5,700
29 May 2014
10,000


Concert Pharmaceuticals Inc executives and stock owners

Concert Pharmaceuticals Inc executives and other stock owners filed with the SEC include: